Press Releases

Press Releases

STATEMENT: Patients For Affordable Drugs Responds to Consolidated Oral Arguments Made In First Appeal Heard Against Medicare Negotiation

Patients For Affordable Drugs Continues to Fight Against Big Pharma’s Attempts to Undermine Medicare Drug Price Negotiation at the Expense of Patients WASHINGTON D.C. — Oral arguments were heard today by the United States Court of Appeals for the Third Circuit in the consolidated cases brought by Bristol Myers-Squibb (BMS), AstraZeneca, and Janssen Pharmaceuticals challenging […]

Press Releases

ICYMI: Patients Score Eighth Legal Victory As Court Rejects Novartis Challenge to Medicare Negotiation Program

Judge Upholds Medicare’s Drug Price Negotiation Program, Dealing Another Blow to Pharmaceutical Industry Lawsuits WASHINGTON D.C. — Marking the eighth win in the ongoing legal battle to preserve the Medicare Negotiation Program, on Friday, October 18th, a district court judge in New Jersey rejected Novartis’ lawsuit against the drug price negotiation program. This ruling adds […]

Press Releases

RELEASE: Patients For Affordable Drugs Exposes Cancer Medication Price Hikes Disproportionately Harming Black And Latino Communities

NBC News Reports Soaring Medication Costs Force Patients Of Color To Make Impossible Choices WASHINGTON D.C. — Patients For Affordable Drugs released new findings today that spotlight five cancer medications with excessive price increases in July – four of which had already been hiked in January this year. Price increases on these drugs, which are […]

Press Releases

STATEMENT: In A Procedural Ruling, Appeals Court Allows Pharma Trade Association To Proceed With Suit Opposing Medicare Negotiation In Fifth Circuit

  District Court Will Now Hear A Suit On The Merits–Like The Industry Has Lost In Every Other Jurisdiction   WASHINGTON D.C. — Today, the U.S. Court of Appeals for the Fifth Circuit ruled that the National Infusion Center Association (NICA) — which is backed by the pharmaceutical lobbying group The Pharmaceutical Research and Manufacturers of America (PhRMA) […]

Press Releases

RELEASE: Patients For Affordable Drugs Files Patient-Focused Amicus Brief Defending The Inflation Reduction Act Against Big Drug Companies’ Challenges

P4AD Counters Industry’s Legal Arguments, Recounts The Sordid History Of Big Pharma’s Opposition To Medicare Negotiation And Tells The Court Of The IRA’s Positive Impact On Millions Of Patients WASHINGTON D.C. — Patients For Affordable Drugs today filed a 30-page amicus brief in the Third Circuit Court of Appeals in cases brought by pharmaceutical giants […]

Press Releases

RELEASE: Patient Advocates Celebrate Second Anniversary Of The Inflation Reduction Act, Look Ahead To Further Lowered Prices

WASHINGTON D.C. — Today marks the second anniversary of President Biden signing the Inflation Reduction Act into law, a historic reform and monumental victory for the millions of Americans who depend on Medicare for their essential medications. Throughout the week, Patients For Affordable Drugs patient advocates participated in events celebrating different provisions of the drug […]

Press Releases

ICYMI: Patient Advocate Judy Aiken Introduces President Biden And Vice President Harris At Celebratory Event To Mark Newly Negotiated Lower Drug Prices Through Medicare

WASHINGTON D.C. — Today, following the announcement of the new lower prices negotiated through Medicare – which marked a historic shift in drug pricing policy – P4AD patient advocate Judy Aiken, who takes Enbrel, one of the first 10 negotiated drugs, introduced President Biden and Vice President Harris at an event focused on the new […]

Press Releases

RELEASE: Biden-Harris Administration Announces First-Ever Lower Medicare Negotiated Drug Prices, Marking Beginning Of New Era In Affordability For Patients On Medicare

  On Average Prices Are Reduced By More Than 60 Percent, With Two Drugs Slashed By More Than 75 Percent Per Month   WASHINGTON D.C. — Today, the Biden-Harris administration released the results of its first-ever drug price negotiations through Medicare, marking a historic shift in drug pricing policy and promising significant savings for nearly nine million American patients. The new […]